References
- Velasco E, Malacara J M, Cervantes F, Diaz de León J, Dávalos G, Castillo J. Gonadotropins and prolactin serum levels during the perimenopausal period: correlation with diverse factors. Fertil Steril 1990; 53: 56–60
- Huerta M R, Mena A, Malacara J M, Diaz de León J. Symptoms at perimenopausal period: its association with attitudes towards sexuality, lifestyle family function and FSH levels. Psychoneuroendocrinology 1995; 20: 135–148
- Øverlie I, Moen M H, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 2002; 41: 68–77
- Slopien R, Maczekalski B, Warenik-Symankiewicz A. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric 2003; 6: 53–57
- Malacara J M, Pérez-Luque E L, Martinez-Garza S, Sánchez-Marin F J. The relationship of estrogen receptor-α polymorphism with symptoms and other characteristics in post-menopausal women. Maturitas 2004; 49: 163–169
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321–333
- Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
- Mohr P E, Wang D Y, Gregory W M, Richards M A, Fentiman I S. Serum progesterone and prognosis in operable breast cancer. Br J Cancer 1996; 73: 1552–1555
- Fentiman I S, Wang D Y, Allen D S, et al. Bone density of normal women in relation to endogenous and exogenous oestrogens. Br J Rheumatol 1994; 33: 808–815
- Aksel S, Schomberg D W, Tyrey L, Hammond C B. Vasomotor symptoms, serum estrogens and gonadotrophin levels in surgical menopause. Am J Obstet Gynecol 1976; 126: 165–169
- Hutton J D, Jacobs H S, Murray M A, James V A. Relation between plasma estrone and estradiol and climacteric symptoms. Lancet 1978; i: 678–681
- Burger H G, Dudley E C, Hopper J L, et al. Prospectively measured levels of serum follicle stimulating hormone, estradiol, and the dimeric inhibins during the menopause transition in a population-based cohort of women. J Clin Endocrinol Metab 1999; 84: 4025–4030
- Kasuga M, Makita K, Ishitani K, et al. Relation between climacteric symptoms and ovarian hypofunction in middle-aged and older Japanese women. Menopause 2004; 11: 631–638
- Guthrie J R, Dennerstein N, Taffe J R, Lehert P, Burger H D. The menopause transition: a 9-year prospective population-based study. Climacteric 2004; 7: 275–289
- Randolph J F, Sowers M, Bondarenka I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopause transition. J Clin Endocrinol Metab 2005; 90: 6106–6112